Drugs / 5-Fluoracil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04864067 | Jun 2021 → May 2026 | rectal cancer | Servicio de Salud Metropolitano Sur Oriente | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5-Fluoracil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04864067 ↗ |